Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  TEL AVIV STOCK EXCHANGE  >  Teva Pharmaceutical Industries Limited    TEVA   IL0006290147

TEVA PHARMACEUTICAL INDUSTRIES LIMITED

(TEVA)
  Report  
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Tel Aviv Stock Exchange
08/15/2019 08/18/2019 08/19/2019 08/20/2019 08/21/2019 Date
2180(c) 2240(c) 2360(c) 2524(c) 2526(c) Last
2 317 398 489 516 1 212 481 2 369 413 1 165 261 Volume
-6.52% +2.75% +5.36% +6.95% +0.08% Change
More quotes
Financials (USD)
Sales 2019 17 173 M
EBIT 2019 4 024 M
Net income 2019 -62,8 M
Debt 2019 25 536 M
Yield 2019 -
Sales 2020 17 068 M
EBIT 2020 4 192 M
Net income 2020 1 911 M
Debt 2020 22 832 M
Yield 2020 -
P/E ratio 2019 -
P/E ratio 2020 -
EV / Sales2019 1,62x
EV / Sales2020 1,47x
Capitalization 2 312 M
More Financials
Company
Teva Pharmaceutical Industries Limited is a pharmaceutical company. The Company is engaged in developing, producing and marketing generic medicines and a portfolio of specialty medicines. The Company operates through two segments: Generic medicines and Specialty medicines. The Company develops,... 
Sector
Pharmaceuticals
Calendar
-
More about the company
Surperformance© ratings of Teva Pharmaceutical Indust
Trading Rating : Investor Rating :
More Ratings
Latest news on TEVA PHARMACEUTICAL INDUST
08/21ANTARES PHARMA : partner Teva Pharmaceuticals issued a press release dated Augus..
AQ
08/21ANTARES PHARMA : Teva Announces Availability of a Generic Equivalent of EpiPen J..
AQ
08/21TEVA PHARMACEUTICAL INDUSTRIES : Fremanezumab Data in The Lancet Demonstrate Cli..
BU
08/20TEVA PHARMACEUTICAL INDUSTRIES : Pharma Shares Up 10% on Release of EpiPen Jr in..
DJ
08/20INVESTIGATION ALERT : The Schall Law Firm Announces it is Investigating Claims A..
BU
08/20TEVA PHARMACEUTICAL INDUSTRIES : Announces Availability of a Generic Equivalent ..
BU
08/16TEVA 96 HOUR DEADLINE ALERT : Approximately 96 Hours Remain; Former Louisiana At..
BU
08/07Patient groups push back against Gilead's pricey HIV prevention treatment
RE
08/07ADR Shares End Higher; Teva Pharmaceutical, Commerzbank Trade Actively
DJ
08/07TEVA PHARMACEUTICAL INDUSTRIES : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCI..
AQ
More news
Analyst Recommendations on TEVA PHARMACEUTICAL INDUST
More recommendations
Sector news : Pharmaceuticals - NEC
08/21LONDON STOCK EXCHANGE : Oil majors, exporters boost FTSE 100; Fed minutes eyed
RE
08/21ABBVIE : Form 8.3 -
DJ
08/21PFIZER : Sets $500 Million Gene-Therapy Expansion in Sanford, N.C.
DJ
08/21AstraZeneca Imfinzi combination fails advanced lung cancer study
RE
08/21Slowing Share Buybacks Remove a Pillar of Stock Market
DJ
More sector news : Pharmaceuticals - NEC
Chart TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Duration : Period :
Teva Pharmaceutical Industries Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends TEVA PHARMACEUTICAL INDUST
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
 
Mean consensus -
Number of Analysts
Average target price
Last Close Price 7,18  $
Spread / Highest target -
Spread / Average Target -
Spread / Lowest Target -
EPS Revisions
Managers
NameTitle
Kåre Schultz President, Chief Executive Officer & Director
Sol J. Barer Chairman
Carlo de Notaristefani Executive Vice President-Global Operations
Michael McClellan Chief Financial Officer & Executive Vice President
Amir Elstein Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
TEVA PHARMACEUTICAL INDUSTRIES LIMITED-56.15%7 654
JOHNSON & JOHNSON2.48%344 675
ROCHE HOLDING LTD.12.16%238 287
MERCK AND COMPANY12.09%219 296
NOVARTIS17.97%204 985
PFIZER-19.40%191 430